To ensure that the changing strategies in PCa care are globally applicable, it is vital that future trials enroll sufficient numbers of participants of Asian ethnicity, as well as other underrepresented groups to generate representative data regarding the efficacy and safety of PSMA-targeted RLT. Here, FOLH1 is linked to posterior cortical atrophy.